MARAVAI LIFESCIENCES HLDGS-A (MRVI) Stock Earnings & Estimates
NASDAQ:MRVI - US56600D1072 - Common Stock
2.33 USD
-0.09 (-3.72%)
2.33 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 883M 10.49% | 288.945M -67.28% | 259.185M -10.30% | 195.57M -24.54% | 209.71M 7.23% | 228.41M 8.92% | 249.25M 9.12% | 270.08M 8.36% | 641.36M 137.47% | 785.67M 22.50% | 942.8M 20.00% | |
| EBITDA YoY % growth | 606.1M 6.69% | 23.599M -96.11% | -13.815M -158.54% | -28.184M -104.01% | -9.287M 67.05% | 3.819M 141.12% | 65.688M 1,620.03% | 71.094M 8.23% | N/A | N/A | N/A | |
| EBIT YoY % growth | 574.2M 5.67% | -25.182M -104.39% | -70.68M -180.68% | -85.107M -20.41% | -55.619M 34.65% | -56.403M -1.41% | 126.48M 324.24% | N/A | N/A | N/A | N/A | |
| Operating Margin | 65.03% | -8.72% | -27.27% | -43.52% | -26.52% | -24.69% | 50.74% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 1.80 13.21% | 0.03 -98.33% | -0.10 -433.33% | -0.32 -219.52% | -0.22 30.99% | -0.13 39.63% | -0.27 -99.23% | -0.26 3.85% | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 -274.65% | -0.07 -15.75% | -0.05 37.24% | -0.05 36.81% | -0.05 36.93% | -0.05 33.43% | -0.03 49.21% | -0.04 19.29% | -0.03 35.25% | -0.03 44.85% |
| Revenue Q2Q % growth | 49.751M -23.69% | 49.434M -12.60% | 52.891M 12.89% | 51.672M 9.02% | 52.712M 5.95% | 53.182M 7.58% | 64.602M 22.14% | 56.34M 9.03% | 57.543M 9.16% | 54.738M 2.93% |
| EBITDA Q2Q % growth | -6.131M -122.33% | -3.606M -111.76% | 1.281M 105.87% | 715.897K 112.94% | 2.676M 143.64% | 3.295M 191.37% | 6.038M 371.35% | 8.339M 1,064.83% | 8.838M 230.27% | 6.457M 95.96% |
| EBIT Q2Q % growth | -19.026M -27.87% | -15.323M 41.54% | -13.015M 64.56% | -11.781M 67.12% | -9.858M 48.19% | -9.86M 35.65% | -3.346M 74.29% | -969K 91.77% | -423.3K 95.71% | -2.774M 71.86% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.08 | -0.07 | -0.01 | -10.61% |
| Q1 2025 Q2Q % growth | -0.08 -300.00% | -0.07 | -0.01 | -9.80% |
| Q4 2024 Q2Q % growth | -0.06 -700.00% | -0.04 | -0.02 | -47.06% |
| Q3 2024 Q2Q % growth | -0.02 -100.00% | -0.01 | -0.01 | -154.98% |
| Q2 2024 Q2Q % growth | 0.00 | 0.00 | 0.00 | -100.00% |
| Q1 2024 Q2Q % growth | -0.02 -166.67% | -0.03 | 0.01 | 22.99% |
| Q4 2023 Q2Q % growth | 0.01 -97.14% | -0.01 | 0.02 | 182.94% |
| Q3 2023 Q2Q % growth | -0.01 -102.70% | 0.01 | -0.02 | -254.15% |
| Q2 2023 Q2Q % growth | 0.00 -100.00% | 0.01 | -0.01 | -100.00% |
| Q1 2023 Q2Q % growth | 0.03 -94.44% | 0.04 | -0.01 | -18.86% |
| Q4 2022 Q2Q % growth | 0.35 -22.22% | 0.35 | 0.00 | 0.38% |
| Q3 2022 Q2Q % growth | 0.37 -15.91% | 0.34 | 0.03 | 9.99% |
| Q2 2022 Q2Q % growth | 0.54 22.73% | 0.46 | 0.08 | 16.50% |
| Q1 2022 Q2Q % growth | 0.54 107.69% | 0.45 | 0.09 | 20.63% |
| Q4 2021 Q2Q % growth | 0.45 246.15% | 0.39 | 0.06 | 14.76% |
| Q3 2021 Q2Q % growth | 0.44 | 0.36 | 0.08 | 22.47% |
| Q2 2021 Q2Q % growth | 0.44 | 0.32 | 0.12 | 36.25% |
| Q1 2021 Q2Q % growth | 0.26 | 0.21 | 0.05 | 24.10% |
| Q4 2020 Q2Q % growth | 0.13 | 0.11 | 0.02 | 17.90% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 47.397M -35.43% | 48.314M | -917K | -1.90% |
| Q1 2025 Q2Q % growth | 46.85M -27.00% | 44.889M | 1.961M | 4.37% |
| Q4 2024 Q2Q % growth | 56.558M -23.72% | 58.491M | -1.933M | -3.30% |
| Q3 2024 Q2Q % growth | 65.2M -2.49% | 68.906M | -3.706M | -5.38% |
| Q2 2024 Q2Q % growth | 73.4M 6.51% | 73.067M | 333K | 0.46% |
| Q1 2024 Q2Q % growth | 64.179M -18.79% | 61.759M | 2.42M | 3.92% |
| Q4 2023 Q2Q % growth | 74.141M -63.78% | 65.667M | 8.474M | 12.90% |
| Q3 2023 Q2Q % growth | 66.865M -65.05% | 77.034M | -10.169M | -13.20% |
| Q2 2023 Q2Q % growth | 68.914M -71.61% | 72.548M | -3.634M | -5.01% |
| Q1 2023 Q2Q % growth | 79.025M -67.65% | 81.315M | -2.29M | -2.82% |
| Q4 2022 Q2Q % growth | 204.7M -10.38% | 209.03M | -4.33M | -2.07% |
| Q3 2022 Q2Q % growth | 191.3M -6.59% | 199.01M | -7.71M | -3.87% |
| Q2 2022 Q2Q % growth | 242.7M 11.43% | 237.91M | 4.79M | 2.01% |
| Q1 2022 Q2Q % growth | 244.3M 64.84% | 236.94M | 7.36M | 3.11% |
| Q4 2021 Q2Q % growth | 228.4M 132.11% | 212.25M | 16.15M | 7.61% |
| Q3 2021 Q2Q % growth | 204.8M 10.26% | 205.53M | -730K | -0.36% |
| Q2 2021 Q2Q % growth | 217.8M | 198.71M | 19.09M | 9.61% |
| Q1 2021 Q2Q % growth | 148.2M | 141.26M | 6.94M | 4.91% |
| Q4 2020 Q2Q % growth | 98.4M 173.33% | 90.804M | 7.596M | 8.37% |
| Q3 2020 Q2Q % growth | 185.745M 73.30% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -18.83% | -430.4% | -9.27% | -12.45% |
| Revenue | -2.58% | -27.21% | -1.58% | -1.16% |